In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions

被引:50
|
作者
Koenigsknecht, Mark J. [1 ]
Baker, Jason R. [2 ]
Wen, Bo [1 ]
Frances, Ann [1 ]
Zhang, Huixia [1 ]
Yu, Alex [1 ]
Zhao, Ting [1 ]
Tsume, Yasuhiro [1 ]
Pai, Manjunath P. [3 ]
Bleske, Barry E. [4 ]
Zhang, Xinyuan [5 ]
Lionberger, Robert [5 ]
Lee, Allen [2 ]
Amidon, Gordon L. [1 ]
Hasler, William L. [2 ]
Sun, Duxin [1 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Room 3353,Bldg 520,1600 Huron Pkwy, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Coll Pharm, Dept Clin Pharm, Ann Arbor, MI 48109 USA
[4] Univ New Mexico, Coll Pharm, Dept Pharm Practice & Adm Sci, Albuquerque, NM 87120 USA
[5] US FDA, Ctr Drug Evaluat & Res, Off Gener Drugs, Off Res & Stand, Silver Spring, MD 20993 USA
关键词
ibuprofen; in vivo dissolution; pharmacokinetics; immediate release; local gastrointestinal concentration; clinical study; CLINICAL PHARMACOKINETICS; DRUG; BEHAVIOR; CLASSIFICATION; FORMULATIONS; TOXICITY; BUFFER; STATE; FOOD;
D O I
10.1021/acs.molpharmaceut.7b00425
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In vivo drug dissolution in the gastrointestinal (GI) tract is largely unmeasured. The purpose of this clinical study was to evaluate the in vivo drug dissolution and Systemic absorption of the BCS class IIa drug ibuprofen under fed and fasted conditions by direct sampling of stomach and small intestinal luminal content. Expanding current knowledge of drug dissolution in vivo will help to establish physiologically relevant in vitro models predictive of drug dissolution. A multilumen GI catheter was orally inserted into the GI tract of healthy human subjects. Subjects received a single oral dose of ibuprofen (800 mg tablet) with 250 mL of water under fasting and fed conditions. The GI catheter facilitated collection of GI fluid from the stomach, duodenum, and jejunum. Ibuprofen concentration in GI fluid supernatant and plasma was determined by LC MS/MS. A total of 23 subjects completed the study, with 11 subjects returning for an additional study visit (a total of 34 completed study visits). The subjects were primarily white (61%) and male (65%) with an average age of 30 years. The subjects had a median [min, max] weight of 79 [52, 123] kg and body mass index of 25.7 [19.4, 37.7] kg/m(2). Ibuprofen plasma levels were higher under fasted conditions and remained detectable for 28 h under both conditions. The AUC(0_24) and C-max were lower in fed subjects vs fasted subjects, and T-max was delayed in fed subjects vs fasted subjects. Ibuprofen was detected immediately after ingestion in the stomach under fasting and fed conditions until 7 h after dosing. Higher levels of ibuprofen were detected in the small intestine soon after dosing in fasted subjects compared to fed. In contrast to plasma drug concentration, overall gastric concentrations remained higher under fed conditions due to increased gastric pH vs fasting condition. The gastric pH increased to near neutrality after feeding before decreasing to acidic levels after 7 h. Induction of the fed state reduced systemic levels but increased gastric levels of ibuprofen, which suggest that slow gastric emptying and transit dominate the effect for plasma drug concentration. The finding of high levels of ibuprofen in stomach and small intestine 7 h post dosing was unexpected. Future work is needed to better understand the role of various GI parameters, such as motility and gastric emptying, on systemic ibuprofen levels in order to improve in vitro predictive models.
引用
收藏
页码:4295 / 4304
页数:10
相关论文
共 50 条
  • [1] Gastrointestinal motility and luminal pH influence in vivo dissolution and systemic drug absorption in human gastrointestinal tract under fasted and fed conditions
    Koenigsknecht, M.
    Baker, J.
    Fioritto, A.
    Tsume, Y.
    Wen, B.
    Dickens, J.
    Yu, A.
    Shedden, K.
    Lee, A.
    Hasler, W.
    Amidon, G.
    Sun, D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 : 103 - 104
  • [2] GASTROINTESTINAL MOTILITY AND LUMINAL PH INFLUENCE IN VIVO DISSOLUTION AND SYSTEMIC ABSORPTION OF DRUG PRODUCT IN HUMAN GASTROINTESTINAL TRACT UNDER FED AND FASTED CONDITIONS
    Koenigsknecht, Mark
    Baker, Jason
    Fioritto, Ann F.
    Tsume, Yasuhiro
    Wen, Bo
    Dickens, Joseph
    Yu, Alex
    Wysocki, Jeffery
    Shedden, Kerby
    Bleske, Barry
    Lee, Allen
    Hasler, William L.
    Amidon, Gordon
    Sun, Duxin
    GASTROENTEROLOGY, 2017, 152 (05) : S206 - S206
  • [3] In vivo bioavailability of a multiparticulate matrix sustained-release theophylline preparation under fed and fasted conditions
    Peh, KK
    Yuen, KH
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (01) : 15 - 18
  • [4] Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen
    Camara-Martinez, I
    Blechar, J. A.
    Ruiz-Picazo, A.
    Garcia-Arieta, A.
    Calandria, C.
    Merino-Sanjuan, V
    Langguth, P.
    Gonzalez-Alvarez, M.
    Bermejo, M.
    Al-Gousous, J.
    Gonzalez-Alvarez, I
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 614
  • [5] Gastrointestinal and Systemic Disposition of Diclofenac under Fasted and Fed State Conditions Supporting the Evaluation of in Vitro Predictive Tools
    Van den Abeele, Jens
    Schilderink, Ronald
    Schneider, Felix
    Mols, Raf
    Minekus, Mans
    Weitschies, Werner
    Brouwers, Joachim
    Tack, Jan
    Augustijns, Patrick
    MOLECULAR PHARMACEUTICS, 2017, 14 (12) : 4220 - 4232
  • [6] Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract
    Yu, Alex
    Baker, Jason R.
    Fioritto, Ann F.
    Wang, Ying
    Luo, Ruijuan
    Li, Siwei
    Wen, Bo
    Bly, Michael
    Tsume, Yasuhiro
    Koenigsknecht, Mark J.
    Zhang, Xinyuan
    Lionberger, Robert
    Amidon, Gordon L.
    Hasler, William L.
    Sun, Duxin
    MOLECULAR PHARMACEUTICS, 2017, 14 (02) : 345 - 358
  • [7] In Vivo Evaluation of the Absorption and Gastrointestinal Transit of Avitriptan in Fed and Fasted Subjects Using Gamma Scintigraphy
    Punit H. Marathe
    Erik P. Sandefer
    Georgia E. Kollia
    Douglas S. Greene
    Rashmi H. Barbhaiya
    Robert A. Lipper
    Richard C. Page
    Walter J. Doll
    U. Y. Ryo
    George A. Digenis
    Journal of Pharmacokinetics and Biopharmaceutics, 1998, 26 : 1 - 20
  • [8] In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy
    Marathe, PH
    Sandefer, EP
    Kollia, GE
    Greene, DS
    Barbhaiya, RH
    Lipper, RA
    Page, RC
    Doll, WJ
    Ryo, UY
    Digenis, GA
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1998, 26 (01): : 1 - 20
  • [9] INTRAGASTRIC BEHAVIOR AND ABSORPTION KINETICS OF A NORMAL AND FLOATING MODIFIED-RELEASE CAPSULE OF ISRADIPINE UNDER FASTED AND FED CONDITIONS
    MAZER, N
    ABISCH, E
    GFELLER, JC
    LAPLANCHE, R
    BAUERFEIND, P
    CUCALA, M
    LUKACHICH, M
    BLUM, A
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (08) : 647 - 657
  • [10] Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update
    Jantratid, Ekarat
    Janssen, Niels
    Reppas, Christos
    Dressman, Jennifer B.
    PHARMACEUTICAL RESEARCH, 2008, 25 (07) : 1663 - 1676